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CHAPTER I 
1. INTRODUCTION 
1.1 Cancer 
Cancer is most lifethretening diseases which are characterized by un-
controlled cellular growth of abnormal cells anywhere in the body. Normally 
body forms new cells  as it need  cells to replace old cells which may die. 
Cancer make this go wrong. Cancer make new cells even when body doesn’t 
require it and the old won’t die.[1] 
Carcinogenesis or oncogenesis or tumouriogenesis is the formation of 
cancer whereby normal cells are transformed to cancer cells. The process is 
characterised by changes at cellular genetic and epigenetic levels and ab-
normal cell division sometimes forming malignant mass. The different phases 
of carcinogenesis is a multi-step process that includes initiation phase, promo-
tion phase, conversion phase and finally progression phase. The growth of 
both normal and cancerous cells is genetically controlled by the balance or 
imbalance of oncogene, proto oncogene and tumor suppressor gene. Multiple 
genetic mutations are required to convert normal cells to cancerous cells. 
Apoptosis and cellular senescence (aging) are normal mechanisms for cell 
death. Cancer cells are genetically unstable, which results in tumor masses of 
heterogeneous cells and makes the cancer a “moving target” for drug thera-
py.[2]  
Cancer treatment include cure, prolongation of life and relief of symp-
toms. Surgery and radiation therapy are the best chance of cure for patients 
with localized cancers, but systemic treatment methods are required for sys-
temic cancers. But main impacts include long-term complications, such as 
infertility, secondary malignancies, effects on physical or intellectual develop-
ment and major organ damage, can negatively affect health and quality of life 
for cancer survivors. 
Induction of apoptosis is one of the most important markers of cytotoxic 
antitumor agents. Some natural compounds including plants induce apoptotic 
pathways that are blocked in cancer cells through various mechanisms in 
cancer cells.  
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1.2. Importance of Herbal treatment and remedies against cancer 
The term “cancer” was used first time by the Hippocrates, father of 
western medicine, Derived from Greek words “carcinoma” and “Karakinos” to 
describe tumor. 
Multiple surveys reported that people with cancer commonly use herbs 
or herbal products. Vinca Alkaloids, Texans, podo phyllotoxin, Camptothecins 
have been clinically used as Plant derived anticancer agents.[3] 
Plant derived anti cancer products introduced during 1981-2002, 48 drugs 
natural products includes 
 vinca alkaloids (vinblastine, vincristine, vindesine, vinorelbine) 
 taxanes (paclitaxel, docetaxel) 
 podophyllotoxin and its derivations (topothecan, irinothecan) 
 Anthra cyclines (doxorubicin, daunorubicin, epirubicin, idarubicin) 
With the invention of vincristine, vinblastine and vinca alkaloid and cy-
totoxic podo phyllotoxin, the study of herbal sources for cancer treatment 
started extremly in 1959. These all lead National Cancer Institute to start a 
program called plant collect in 1960. These findings resulted in discovery of 
novel chemotypes with cytotoxic activities including the taxans, camptothe-
cins.  
Even from the history natural products have afforded as a rich source 
of compound with many medicinal applications. Ancient Unani manuscripts 
Egyptian papyrus and Chinese writings described the use of herbs.  Evidence 
exist that Unani Hakims, Indian Vaids and European and Mediterranean cul-
tures were using herbs for over 4000 years as medicine. Indigenous cultures 
such as Rome, Egypt, Iran, Africa and America used herbs in their healing 
rituals, while other developed traditional medical systems such as Unani, 
Ayurveda and Chinese Medicine in which herbal therapies were used sys-
tematically.[4][5] 
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Traditional systems of medicine continue to be widely practised on 
many accounts. Population rise, inadequate supply of drugs, prohibitive cost 
of treatments, side effects of several synthetic drugs and development of re-
sistance to currently used drugs for infectious diseases have led to increased 
emphasis on the use of plant materials as a source of medicines for a wide 
variety of human ailments. Being an Indian especially we have to be proud 
about many natural methods of treatment including the important Ayurvedic 
system of medicine. Where we could find many effetive herbal formulations 
and still growing field of medicine. 
So it has become a responsibility as well as competition in the field of 
research to find plant constituents against the major threatening disease can-
cer. Cancer is considered as the major cause of death similiar to myocardial 
infraction. Millions die and at same time suffering the after effects and impacts 
of cancer. Last century was able to perform great advances in modern medic-
inal science to control diseases. But many diseases like cancer are not yet 
curable fully. Though all are approaching Allopathic system of medicine most-
ly traditional or folk system of medicine are runnnig parallel.[6] 
Not only curing has become trend all are ready to follow the word “pre-
vention is better than cure”. Nowdays awareness programmes and precau-
tious measures against cancer are going well. Where herbal formulations find 
the way of it’s importance as preventive measures. 
The plant Nigella sativa seed has been an important nutritional flavour-
ing agent and natural remedy for many ailments for centuries in ancient sys-
tem of medicine including Unani,Ayurveda Chinese and Arabic medicines[7]. 
Traditionally, there is a common Islamic belief that blackseed is a panacea for 
all ailments,but cannot  prevent aging or death. It originated from Southeast-
ern Asia and also used in ancient Egypt, Greece, Middle east and Africa.  Co-
lon and rectal cancer is one of the common cancers among men and women 
from the India  as per recent reports. It ranks sixth or seventh among all other 
cancers. The incidence (newly diagnosed cases of cancer in a year) of colon 
and rectal cancers in India is about 4 patients per 1,00,000 population for both 
sexes together. [8] 
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1.3.Colon 
The colon is another term for the large intestine, it is the lowest part of 
the digestive system. Inside the colon, water and salt from solid wastes are 
extracted before the waste moves through the rectum and exits the body 
through the anus. 
 
Fig.No: 1: Anatomy of colon 
 
The colon is made of several sections. The ascending colon travels up 
the right side of the abdomen. The part that sits across the abdomen is called 
the transverse colon. The descending colon runs down the left side of the ab-
domen. The next segment, the sigmoid colon, joins the descending colon to 
the rectum. Stool leaves the body through an opening called the anus.
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1.3.1.Histology of Colon 
Fig. No: 2: Histology of colon 
 
 It have mucosa which have epithelium, intestinal glands(Glands of 
Lieberkuhn), Lamina prpopria and muscularis mucosa. 
 A submucosa which muscularis externa containing inner circular and outer 
longituidinal smooth muscle layers. 
 The outermost serosa 
 Lymphatic nodules in the lamina propria and submucosa. 
 A myentric (Auerbach)nerve plexus(Parasympathomimetic)exists between 
the muscularis externa layer.
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1.3.2 Blood supply to colon 
The colon is supplied with the superior mesenteric artery(SMA),the inferior 
mesenteric artery (IMA), and branches of the internal iliac arteries. 
 
Fig. No 3: Blood supply to colon 
 
 The SMA branches to the middle idic right colic and ileocolic arteries 
which supply the right colon and the right half of the transverse colon. 
 The IMA gives rise into left colic sigmoid and superior rectal 
hemmorhoids areteries. 
 The distal rectum is supplied by inferior and middle rectal (hemmorhoi-
dal)arteries which are branches of internal iliac artery. 
 There is an extensive mesenteric collateral circulation that provides 
substantial protection from ischemic insults. 
 The SMA and IMA communicate through the marginal artery of Drum-
mond which runs along the splenic flexure and the arc of Riolan. 
 The marginal artery of Drummond absent or underdeveloped in 5% 
population. 
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1.4.Colon Cancer 
Cancer is a class of disease characterised by the uncontrolled cell 
growth.Colon cancer forms when the same happens. Depending on the type 
of cancer, 5 to 20 years may elapse between the carcinogenic phases and the 
development of a clinically detectable cancer. The final stage of neoplastic 
growth called as progression, which involves further genetic changes leading 
to increased. Most colon cancers originate from small non cancerous tumours 
adenomatous polyps that forms the inner walls of large intestine. Even colon 
polyps if not removed may lead to colon cancers have reported. Colon cancer 
cells will invade to other healthy tissue that is near to the tumour causing fur-
ther complications. Incidence of colon cancer is higher in developed coun-
tries[9]. But in India it was reported in low rate which now is going up with 
modern life style.[10]  
 
Fig.No 4: Correlation between CRC Progression and the accumulation of 
genetic alterations 
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1.4.1.Pathology Of Colon Cancer 
Researchers have studied tha mechanism behind colon cancer formation 
significantly. And also it’s development. The existence of of major three pathways 
are reported.Chromosomal instability microstellite instability and CpG island 
methylator phenotype. Other important one study recently reported that several 
genetic and epigenetic changes are important in determining patients survival 
probability. 
Several epidemiological studies have confirmed the involvement of nu-
merous environmental and dietary factors, such as cigarette smoking, alcohol 
abuse, a diet high in fat and low in fiber, a sedentary lifestyle and obesity .  
Colorectal cancer (CRC) is the second most common cancer in women 
and the third most common in men globally. CRC arises from one or a combina-
tion of chromosomal instability, CpG island methylator phenotype, and microsat-
ellite instability. [11] 
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Table No.1: Overall Prevalence of Genetic Mutations in CIN-positive Colo-
rectal   Cancers 
      Reported by US national library of medicine [11] 
Gene Chromosomal 
location  
Prevalence of 
mutation 
Function of prod-
uct 
Oncogene 
KRAS 
 
12p12 
 
~30-50% 
 
Cell prolifera-
tion,survival 
CTNNB1 
 
3p22 
 
~4-15% 
 
Regulation of Wnt 
pathway 
PIK3CA 3q26 ~20% Cell proliferation, 
survival 
 
Tumour suppressor genes 
 
 
APC 
 
5q21 
 
~30-70% 
Inhibition of Wnt 
signalling 
 
TP53 
 
 
17p13 
 
 
~40-50% 
 
Cell cycle arrest, 
apoptosis 
 
SMAD4,SMAD2 
 
18q21 
 
~10-20-% 
 
Intracellular media-
tors of TG – F-β 
Pathway 
DCC 18q21 ~6% Cell surface recep-
tor for netrin-1 
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1.4.1.1.Chromosome instability pathways  
“Wnt signalling” : Here the tumuriogenic process involves different mitotic 
spindle check point regulators and proteins that mutually influence mitotic chro-
mosome stability.Which is charecterised by the early adenomatous polyposis . 
Wnt involves pathways  made of proteins pass signals into a cell through cell 
surface receptors.[12] 
Fig. No:5: Chromosome Instability Pathways 
 
1.4.1.2.RAS pathway: The adenoma to carcinoma transition is regulated initially 
by the K-ras gene, a proto-oncogene that encodes for the GTPase protein 
involved in the transduction and propagation of extracellular signals—e.g., 
mitogen-activated protein kinase (MAPKs). Mutations of K-ras lead to a perma-
nently active state that permits the cell to evade apoptosis and acquire a growth 
advantage.  
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Fig.No: 6: RAS Pathway 
 
1.4.1.3. P 53 system: 
 p53 loss of function is frequently present in the later stages of colorectal 
tumorigenesis. The p53 gene is located on chromosome 17p and its mutation is 
one of the key steps in colorectal carcinogenesis and stimulates high proliferative 
activity through the loss of cell cycle control and apoptosis. 
1.4.1.5.Other pathways: 
 An often co-occurring molecular alteration with the p53 loss is the LOH 
of chromosome 18q (65.4%) , where the genes Smad2, Smad4 and DCC 
genes are located. LOH of 18q has been associated with a strong negative 
prognosis in colon cancer, in particular with high metastatic potential. 
Microsatellite instability:  
Which depicts the form of instability in case of sporadic colorectal can-
cer (15%)and 95% in case of herditary non polyposis syndrome.[13] 
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CIMR (chromosomal instability in m RNA) and “serrated “ pathway 
Here the mechanism is hyper methylation of CpG dinucleotide se-
quences localized in promotor regions of genes involved in cell cycle regula-
tion, apoptosis, angiogenesis, DNA repair, invason and adhesion. And there-
by observed loss of gene expression. 
1.4.2.Symptoms Of Colon Cancer[14] 
 Changes in stool consistency 
 Diarrhoea or constipation 
 Narrow stools 
 Rectal bleeding or blood in the stool 
 Pain, cramps, or gas in the abdomen 
 Pain during bowel movements 
 Continual urges to defecate 
 Weakness or fatigue 
 Unexplained weight loss 
 Irritable bowel syndrome (IBS) 
 Iron deficiency. 
 
1.4.3.Treatment Of Colon Cancer 
Stage “0”of colon cancer- Here it appears as polyps. And polypectomy can 
be performed. 
Stage “1” colon cancer -Colon cancer layers of colon wall hre. But they 
have not spread out of the wall.Here treatment is Partial colectomy.  
Stage “2” of colon cancer- Stage where cancers have grown through wall of 
colon to nearby tissues but have not yet spreded to lymph nodes.Can treat by 
surgery along with lymph nodes. 
Sometimes adjuvant chemotherapy is recommended if  
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 Cancer looks very abnormal 
 Has grown to lymph and blood vessels 
 Cancer have blocked colon 
 Perforation in colon wall 
Sometimes radiation therapy is given to kill remaining cancer cells if present. 
Stage “3”of colon cancer- Here cancer have grown to nearby lymph nodes 
.Surgery and chemotherapy is recommended. 
Stage “4” of colon cancer- Have spread to other organs from co-
lon.Sometimes to liver, lungs, or distant lymph. Here chemotherapy before 
and after surgery is recommended. 
The main drugs used in the adjuvant treatment of colon cancer are a combi-
nation of the following: 
• 5-fluorouracil (5FU), which is often given with the vitamin   folinic acid (leu-
covorin) 
• capecitabine  
• oxaliplatin  
• irinotecan  
• raltitrexed  
• mitomycin C. 
 
The most commonly-used chemotherapy drugs for advanced bowel cancer 
are:  
 Bevacizumab 
Used to treat many types of cancers and a specific eye disease. Blocks 
endothelial cell proliferation and new vessel formation by inhibition of 
VEGF interaction on surface of endothelial cells. 
 Irinotecan Hydrochloride 
Inhibit DNA replication and transcription  
 Capecitabine: 
 It is a prodrug of 5-FU absorbed from intestine. 
 Cetuximab: 
Thymidine synthase inhibitor hence by inhibitng thymidine monophos-
phate, which is the active form of thymidine required for de novo syn-
thesis of DNA. 
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 Ramucirumab  
It is directed against the Vascular Endothelial Growth Factor Receptor 
2 (VEGFR2) as an antagonist for blocking the growth factor binding on 
Receptor 
 Oxaliplatin 
Formation of Platinum DNA adducts for blocking DNA replication and 
are cytotoxic than cisplatin 
 Cetuximab 
Expression of (EGFR) being reported in cancer of colon rectum head 
and neck, cetuximab bind specifically on EGFR on both normal and 
tumour cells. 
 5-FU  
Thymidine synthase inhibitor hence by inhibitng thymidine monophos-
phate, which is the active form of thymidine which is a nucleoside re-
quired for DNA replication. 
 Leucovorin Calcium 
As an adjuvant to get rid of the blood cell disorders due to cytotoxic 
drugs 
 Trifluridine  
Nucleic acid synthase inhibitor  
 Panitumumab 
Binding to EGFR and thereyby inhibits binding of all ligands in EGF 
 
1.4.3.1.Side Effects 
Chemotherapy can temporarily reduce the production of white blood cells in 
your bone marrow, making you more prone to infection. This effect can begin 
about seven days after treatment has been given, and your resistance to in-
fection usually reaches its lowest point about 10–14 days after chemotherapy. 
Bruising or bleeding 
Anaemia (low number of red blood cells) Chemotherapy can reduce the num-
ber of red blood cells, which carry oxygen around the body. A low red blood 
cell count is called anaemia. 
Tiredness (fatigue). 
Nausea and vomiting 
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Diarrhoea 
Sore throat 
Hair loss 
Numbness or tingling in hand or feet 
 
1.5.DMH (Di Methyl Hydrazine) As Colon Carcinogen 
The colon carcinogen 1,2-dimethylhydrazine (DMH) has been widely 
used to study chemically induced colon cancer. Whatever the mode of admin-
istration, DMH specifically induces tumours within the descending colon of rat 
and the histopathology is found to be similar to that observed for human spo-
radic colon tumours[15] 
DMH mechanism is alkylating DNA and the pro-mutagenic lesion O6-
methylguanine (O6-MeG) has been detected in DNA from various rat and 
mouse tissues following exposure to DMH. 
Nowdays DMH induced colon cancer model represents useful research 
tool for the studies of colon carcinogens and chemopreventive agents. DMH 
and its metabolite AOM are the agents widely used in experimental models 
colorectal carcinogenesis in rodents. They are highly specific indirect colorec-
tal carcinogens that induce the initiation and promotion steps of colorectal 
carcinogenesis yielding colorectal tumour lesions in a dose-dependent man-
ner in rats, mice and hamsters. 
1.5.1.Chemical Structure of DMH 
H3C- NH- NH- CH3 
 
1.5.2.Dimethyl Hydrazine metabolism 
DMH is highly specific colorectal carcinogen[16] that will be metabolical-
ly activated by liver with a series of reactions through intermediates azome-
thane,AOM and methylazoxymethanol(MAM) to the ultimate carcinogenic me-
tabolite, highly reactive methyldiazonium ion. 13,MAM is excreted into the bile 
and transported to the colon or enter directly into epithelial cells of the colon 
from the blood circulation. Some studies have demonstrated that rat colon 
epithelial cells are capable of metabolising DMH into carcinogenic metabolite 
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without previous metabolism by other tissues or colon bacteria. Although in-
testinal flora and bile acids have influence on the incidence of tumours. DMH 
induced colon cancer is a multistep process involving a series of pathological 
alterations, such as formation of aberrant cryptic foci (discrete microscopic 
lesion; Ionov et al., 1993).[17] 
It was already reported about the ove expression of inducible nitric oxide syn-
thetase and cox-2 in colorectal cancer [18] 
 
1.5.3.Tumour lesions induced by DMH 
DMH is highly specific for colonic epithelium and induces tumours mostly in 
large bowel. Colon specific susceptibility for this carcinogen is a result of a 
delayed or incomplete repair of damaged DNA in the colon compared to other 
organs leading to accumulation of mutations, and in a small proportion of cells 
giving rise to CRC. 
 
1.6.Colorectal Tumour Lesions 
Aberrant crypt foci 
The first specific morphologically identifiable lesions for colonic carcin-
ogenesis are aberrant crypt foci (ACF). They can be identified in the colon of 
carcinogen treated mice by the light microscopic examination of the mucosal 
surface of colons that had been stained with methylene blue. ACF are can be 
distinguished from normal crypts by their darker staining and larger size, ellip-
tical shape, thicker epithelial lining and larger perycriptal zone. 
Histologically, colorectal epithelial tumours are divided into adenomas 
and carcinomas. Tumours that penetrate through the muscularismucosa into 
the submucosa are classified as carcinomas. Adenoma is a type of non-
cancerous tumor or benign that may affect various organs. It is derived from 
the word “adeno” meaning 'pertaining to a gland'. Adenomas are character-
ized by hypercellularity with enlarged, hyperchromatic nuclei,varying degrees 
of nuclear stratification, loss of polarity and decreased mucine excretion. ACF 
may appear predominantly in distal colon followed by proximal colon[19]  
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1.7.MTT Assay[20] 
Principle 
MTT, a yellow tetrazole, is reduced to purple formazan in living cells. A 
solubilization solution (usually either dimethyl sulfoxide, an acidified ethanol 
solution, or a solution of the detergent sodium dodecyl sulfate in dilut-
ed hydrochloric acid) is added to dissolve the insoluble pur-
ple formazan product into a colored solution. The absorbance of this colored 
solution formed can be quantified by measuring at a cer-
tain wavelength (usually between 500 and 600 nm) by a spectrophotometer. 
The degree of light absorption depends on the solvent. 
MTT is membrane permeable via endocytosis and is reduced by  active 
mitochondria in living cells. In addition, MTT was found to be membrane im-
permeable. Some reports suggest that MTT is taken up by cells through en-
docytosis and that reduced MTT formazan accumulates in the endoso-
mal/lysosomal compartment and is then transported to the cell surface 
through exocytosis. 
Fig. No:7: mechanism behind MTT assay 
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CHAPTER II 
2.REVIEW OF LITERATURE 
Osama Adnan Kensara, et  al.,  (2016) [21] have explained that thy-
moquinone which is the major constituent of Nigella Sativa subdues tumor 
growth and potentiates the chemopreventive effect of 5-fluorouracil on the 
early stages of colorectal carcinogenesis in rats. 
Riad Agbaria, et al., (2015)[22] have studied the anticancer activity of 
Nigella sativa and it’s relation relationship with the thermal processing and 
quinone composition of the seed.That data indicated that controlled thermal 
processing of NS seeds (at 50°C–150°C) produces significantly higher anti-
cancer activity associated with a higher thymoquinone oil content, and inhibits 
the NF-κB signaling pathway. 
Arshad Rehmani, et al., (2014)[23] have demonstrated the therapeutic 
effects of Nigella Sativa seed and its constituents in the diseases treatment 
and prevention through modulation of antioxidant, anti-inflammatory, anti-
tumor, hepato-protective and other genetic activities. 
Amulya sridhar, et al., (2014)[24] have performed the elucidation of 
molecular targets of bioactive principles of Nigella sativa seed or black cumin  
relevant to its anti-tumour functionality - In this study, three different Insilico 
Reverse Screening approaches have been employed for identifying the puta-
tive molecular targets of the bioactive principles in Black cumin (thymoqui-
none, alpha-hederin, dithymoquinone and thymohydroquinone) relevant to its 
anti-tumour functionality. 
Al Khalaf,  et al., (2013) [25] have reviewed the anticancer and anti mi-
crobial activity of Nigella Sativa seed oil. They reviewed the anticancer activity 
of a thymoquinone by inhibition of NF kappa B and oncogene expression. 
Randhava,  et al.,(2011)[26] at University of  Damam have brought a 
summary of all work done on Nigella sativa seed against cancer emphasizing 
the safety of  N.Sativa oil when given orally. They concluded about the abun-
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dant active constituent Thymoquinone  and it’s safety mechanism of action 
described earlier too. 
Md Asaduzzaman Khan, et al., (2011)[27]have  described about the 
anticancer actions of Nigella sativa seed based on it’s major constituent Thy-
moquinone. 
Effenberger, et al., (2010) [28] explained that derivatives of TQ bearing 
terpene-terminated 6-alkyl residues were tested in HL-60 cells and 518A2 
melanoma by They found the derivatives induce apoptosis associated with 
DNA laddering, a decrease in mitochondrial membrane potential and a slight 
increase in reactive oxygen species. They tested terpene-terminated 6-alkyl 
residues of TQ on multidrug-resistant KB-V1/Vb1 cervical carcinoma and 
found the derivatives inducing cell death by apoptosis. 
Boskabady, et al., (2010) [29] have explained that Nigella Sativa seed 
it has a potent antihistaminic effect on airways of asthmatic patients. 
 Maria P Torres, et al., (2010) [30]evaluated the down-regulatory effect 
of TQ on MUC4 in pancreatic cancer cells. 
Nader, et al., (2010) [31]showed that the active ingredients of N. sativa 
have beneficial effects against many diseases, including cancers. For exam-
ple, it is effective in the diminishing the risk of atherosclerosis by decreasing 
the serum low density lipoprotein cholesterol level and increasing the serum 
high density lipoprotein cholesterol levels. 
Gawahar Shafi, et al., (2009)[32] reported that methanol, n-Hexane and 
chloroform extracts of N. sativa effectively killed HeLa (human epithelial cervi-
cal cancer) cells by inducing apoptosis. 
And later  it was proved that black cumin seeds have anticarcinogenic 
and antimutagenic properties Bourgou et al., 2008. 
Kanter, et al., (2009)[33] examined that Nigella sativa  seed exerts 
therapeutic and protective effect in diabetes by decreasing morphological 
changes and preserving pancreatic beta-cell integrity  and by beneficially 
changing the hepatic enzyme activities. 
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Banerjee, et al., (2009)[34] proved about the Nigella Sativa seed extract 
which can abrogate gemcitabine- or oxaliplatin-induced activation of NF-
kappa B, resulting in the chemosensitization of pancreatic tumors to conven-
tional therapeutics. They said high molecular weight glycoprotein mucin 4 
(MUC4) is aberrantly expressed in pancreatic cancer and contributes to the 
regulation of differentiation, proliferation, metastasis, and the chemo-
resistance of pancreatic cancer cells. 
Pari and Sankaranarayanan, (2009)[35];  brought the evidence that 
N.Sativa seed is effective against hypertension.That study evaluated the anti-
hyperglycemic potential of thymoquinone (TQ), major constituent of Nigella 
sativa seeds on the activities of key enzymes of carbohydrate metabolism in 
streptozotocin (STZ)-nicotinamide (NA)-induced diabetic rats.And a significant 
effect in hepatic enzyme activities and thereby Anti hyperglycaemic effect was 
seen 
Chehl, et. al., (2009)[36] have showed that TQ, the major constituent of 
N. Sativa seed oil extract, induced apoptosis and inhibited proliferation in PDA 
(pancreatic ductal adenocarcinoma) cells. They also suggested TQ as a novel 
inhibitor of pro-inflammatory pathways, which provides a promising strategy 
that combines anti-inflammatory and proapoptotic modes of action. 
Nagi and Almakki, (2009) [37] reported that oral administration of TQ is 
effective in increasing the activities of quinone reductase and glutathione 
transferase and makes TQ a promising prophylactic agent against chemical 
carcinogenesis and toxicity in hepatic cancer. 
El Shenawy, et al., (2008)[38]  have discussed about the protective ef-
fect of Nigella sativa in kidney tissue against oxygen free radicals, preventing 
renal dysfunction and morphological abnormalities with evidence. 
Aggarwal, et al., (2008)[39] reviewed about the seed Nigella Sativa  
that it is called black cumin in English, while in old Latin it was called ‘Pana-
cea’ meaning ‘cure all’; in Arabic it is termed as ‘Habbah Sawda’ or ‘Habbat el 
Baraka’ translated as ‘Seeds of blessing’. It is also known as ‘Kalo jeera’ (in 
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Bangladesh), ‘Kalonji’ (in India) and ‘Hak Jung Chou’ in (China). Both seeds 
and oil extracted from this plant are used in medicinal purposes. 
Yi et al., (2008)[40] found that TQ blocked angiogenesis in vitro and in 
vivo, prevented tumor angiogenesis in a xenograft human prostate cancer 
(PC3) model in mouse, and inhibited human prostate tumor growth at low 
dosage with almost no chemotoxic side effects. Furthermore, they observed 
that endothelial cells were more sensitive to TQ-induced cell apoptosis, cell 
proliferation, and migration inhibition compared with PC3 cancer cells. TQ 
also inhibited vascular endothelial growth factor-induced extracellular signal-
regulated kinase activation but showed no inhibitory effects on vascular endo-
thelial growth factor receptor 2 activation. 
Khattab, et al., (2007)[41]explained that Thymoquinone inhibits tumor 
angiogenesis and tumor growth through suppressing AKT and extracellular 
signal-regulated kinase signaling pathways which is the major constituent of 
Nigella Sativa seed. 
Ait Mubrek, et al., (2007)[42] evaluated the invitro and in vivo anti-
cancer effects of Nigella Sativa seed extracts .The essential (IC 50=2%)oil 
and ethyl acetate (IC50 = 0.75%) extracts were more cytotoxic against the 
P815 cell line than the butanol extract (IC50= 2%). Similar results were ob-
tained with the Vero cell line. In this study a comparitive data regarding the in 
vitro cytotoxic effect of the essential oil and the ethyl acetate and butanol ex-
tracts of N. sativa seeds on a panel of tumor cell lines was provided. 
Kaseb, et al.,(2007) [43] demonstrated that N. sativa, inhibited DNA 
synthesis, proliferation, and viability of cancerous (LNCaP, C4-B, DU145, and 
PC-3) but not non-cancerous (BPH-1) prostate epithelial cells by down-
regulating AR (androgen receptor) and E2F-1 (a transcription factor.) 
Xia Wang and Yong Lin, (2007) [44]have concluded that , Tumor ne-
crosis factor (TNF) is a multifunctional cytokine that plays important roles in 
diverse cellular events such as cell survival, proliferation, differentiation, and 
death. As a pro-inflammatory cytokine, TNF is secreted by inflammatory cells, 
which may be involved in inflammation-associated carcinogenesis. TNF ex-
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erts its biological functions through activating distinct signaling pathways such 
as nuclear factor κB (NF-κB) and c-Jun N-terminal kinase (JNK). NF-κB is a 
major cell survival signal that is anti-apoptotic while sustained JNK activation 
contributes to cell death. 
Norwood, et al. (2006)[45] explained that how Thymoquinone as 
chemotherapeutic agent on SW-626 colon cancer cells, in potency, which is 
similar to 5-flurouracil in action.  The results of this study have shown a similar 
significant decrease in cell number as early as 24 hours in the groups treated 
with TQ and EGCG compared to 5-FU. Increased cellular damage were evi-
dent after 24, 48, and 72 hours and in all treated groups compared with the 
control. Reduced cell numbers in the treated groups suggests the possibility 
that TQ and EGCG may have similar chemotherapeutic effects on cancer 
cells as 5-FU. 
El-Mahdy, et al., (2005)[46] reported that TQ exhibits anti-proliferative 
effect in human myeloblastic leukemia HL-60 cells. TQ in Nigell Sativa exhib-
its antiproliferative effect, induces apoptosis, disrupts mitochondrial mem-
brane potential and triggers the activation of caspases 8, 9 and 3 in myelo-
blastic leukemia HL-60 cells. The apoptosis induced by TQ was found to be  
inhibited by a general caspase inhibitor, z-VAD-FMK; a caspase-3-specific 
inhibitor, z-DEVD-FMK; as well as a caspase-8-specific inhibitor, z-IETDFMK. 
Moreover, the caspase-8 inhibitor blocked the TQ-induced activation of 
caspase-3, PARP cleavage and the release of cytochrome c from mitochon-
dria into the cytoplasm. 
Thabrew, et al., (2005),[47]  investigated the cytotoxic activity of N. sa-
tiva seed was tested on the human hepatoma HepG2 cell line by and 88% 
inhibitory effect on HepG2 was found after 24-hr incubation with different con-
centrations (0–50 mg/ml) of the N. sativa extract.  
El-Aziz, et al., (2005)[48] could find that N. sativa, in combination with 
melatonin and retinoic acid reduced the carcinogenic effects of DMBA (7, 12-
di-methylbenz(a)anthracene) in mammary carcinoma of rats. 
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Awad, (2005)[49] examined that oil of N. sativa could decrease the fibri-
nolytic potential of the human fibrosarcoma cell line (HT1080) in vitro.  In this  
study, Nigella sativa oil (NSO) was  evaluated for it’s  effect on the fibrinolytic 
potential of the fibosarcoma cell line HT1080 to elucidate whether this oil 
might have an antitumor activity through its modulation of the fibrinolytic po-
tential of such cells. 
Rooney and Ryan, (2005)[50] have stated that there is no preventive 
role of TQ on MIA PaCa-2 (pancreas carcinoma) cells. As HEp-2 human lar-
yngeal carcinoma cells were the most susceptible, have sought to better un-
derstand the mechanisms involved by using buthionine sulfoximine (BSO), a 
selective inhibitor of glutathione (GSH) synthesis, to determine the importance 
of GSH in the apoptosis elicited, using cisplatin as internal standard. BSO 
significantly enhanced alpha-hederin- and cisplatin- mediated toxicity as as-
sessed by the MIT assay, without changes in apoptosis or necrosis levels. 
Khan and Sultana, (2005)[51] reported the chemo-preventive effect of 
N. sativa against ferric nitrilotriacetate (Fe-NTA)-induced renal oxidative 
stress, hyper-proliferative response and renal carcinogenesis. Treatment of 
rats orally with N. sativa (50 100 mg/kg body wt) resulted in significant de-
crease in H2O2 generation, DNA synthesis and incidence of tumors. 
Gali-Muhtasib, et al., (2004)[52] proved that ThymoQuinone is anti-
neoplastic and pro-apoptotic against colon cancer cell line HCT116. It was 
shown to possess potent chemopreventive activities against DMBA-initiated 
TPA-promoted skin tumors in mice. Despite the potential interest in TQ as a 
skin antineoplastic agent, its mechanism of action has not been examined yet. 
Using primary mouse keratinocytes, papilloma (SP-1) and spindle (I7) carci-
noma cells, they studied the cellular and molecular events involved in TQ's 
antineoplastic activity. 
Newell and Heddle, (2004)[53]; have performed 1, 2 Dimethyl hydra-
zine (DMH), is a potent colon carcinogen, inducing colorectal tumors in exper-
imental animals and is the most widely used model of chemically induced co-
lon. 
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Ali and Blunden, (2003)[54] stated that Nigella Sativa seeds contain 
both fixed and essential oils,proteins,alkaloids, and saponin as well as much 
of the biological activities of the Nigella Sativa  seeds have been shown to be 
due to thymoquinone, the major component of the essential oil, which is also 
present in the fixed oil. 
Swamy and Huat, (2003) [55]also have investigated the antitumor activ-
ity of α-hederin from N. sativa against LL/2 (Lewis Lung carcinoma) in BDF1 
mice. Swamy and Huat (2003) observed that α-hederin also induced death of 
murine leukemia P388 cells by a dose- and time-dependent increase in apop-
tosis. 
Badary et al., (2003) [56] proved the antioxidant properties of Nigella 
Sativa seeds. 
Farah and Begum, (2003) [57] have examined aqueous and alcohol ex-
tracts of N.Sativa in vitro in inactivating MCF-7 breast cancer cells. objective 
of this study was to expose MCF-7 breast cancer cells to aqueous and alcohol 
extracts and in combination with H2O2 as an oxidative stressor. Measurement 
of cell survival under various concentrations and combinations was conducted 
using standard cell culture techniques, exposure protocols in 96 well plates 
and Fluoro-spectrosphotometry. Following cellular growth to 90% confluency, 
exposure to water (WE) and ethanol (AE) extracts of N. sativa and H2O2 was 
performed. Toxicity index (LC50) was calculated from percent survival using 
regression analysis. Results showed that the alcohol extract and its combina-
tions were able to completely inactivate the MCF-7 cells (LC50 ranged from 
377.16-573.79 in descending potency for H2O2 + AE, AE and Mix of WE and 
AE). H2O2 alone effectively inactivated MCF-7 cells (LC50 = 460.94) 
Salim and Fukushima ., (2003)[58] demonstrated that the volatile oil of 
N. sativa has the ability to inhibit colon carcinogenesis of rats in the post-
initiation stage, with no evident adverse side effects.  
Chemopreventive effects of orally administered Nigella sativa oil on the induc-
tion and development of 1,2-dimethylhydrazine-induced aberrant crypt foci 
(ACF), putative preneoplastic lesions for colon cancer, were investigated in 
Fischer 344 rats. 
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Also, Mabrouk, et al., (2002)[59] proved that supplementation of diet 
with honey and N. sativa has a protective effect against MNU (methylnitro-
sourea)-induced oxidative stress, inflammatory response and carcinogenesis 
in lung, skin and colon. 
Ghosheh, et al., (1999)[60] described the quantification of four pharma-
cologically important components: thymoquinone (TQ), dithymoquinone 
(DTQ), thymohydroquinone (THQ), and thymol (THY), in the oil of N. sativa 
seed by HPLC.  
Tsunoda, et al., (1998)[61] investigated a colon cancer model in rats as 
an in vivo secondary screen for the general evaluation of new anticancancer 
agents against colorectal cancer. 
Salomi et al., (1991)[62]  reported   that topical application of N. sativa 
extract inhibited two-stage initiation/promotion [dimethylbenz[a]anthracene 
(DMBA)/croton oil] skin carcinogenesis in mice. As well as intraperitoneal ad-
ministration of N. sativa (100 mg/kg body wt) 30 days after subcutaneous ad-
ministration of MCA (20-methylcholanthrene) inhibited soft tissue sarcomas to 
33.3% compared with 100% in MCA-treated controls. 
 Salomi, et al., (1989)[63] have prepared an extract of Smilax china, 
Hemidesmus indicus and Nigella Sativa on the ratio 3:2:1, prepared by boiling 
in water. Cytotoxic studies with the three components showed activity in Ni-
gella sativa at a concentration of 25 microgram equivalent of the dry powder 
against Dalton's lymphoma ascites cells. Animal experiments indicated the 
retarded growth of ascites as compared to the controls with a longivity of 90%. 
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CHAPTER III 
3. AIM AND OBJECTIVES 
 The different types of cancer has most prevalence life threatening dis-
ease in the globe due to uncontrolled cell division and growth in affected area 
therefore badly affecting normal existence of life. Those who are affected with 
cancer can cure or reduce the symptoms with natural products.In india most 
of the peoples affected Colon cancer which included man 73% and woman 
37%. Modern day chemotherapy treatment induced severe toxicities including 
weakening of body than before treatment of drugs. 
Plant based medicines play an essential role in primary health care 
system. As well as importance of plant derived medicines are seriously under 
estimated in modern medicine. In recent years much attention has been 
shown therapeutic impact of plant derived drugs and phytochemicals on vari-
ous infectious and non infectious diseases of cancer. Compared to it’s alter-
native forms traditional medicines were practicing siddha, auyurveda and un-
nani but no scientific evaluation. The selection of this plant Nigella Sativa was 
made on the basis of literature survey to found the parameters such as: 
 High therapeutic value 
 Wide use in Indian Traditional System of Medicine 
 Degree of research work which is not yet performed 
So this work primarily aim to evaluate the anticancer activity of plant Nigel-
la sativa stem extract on cell proliferation of colon carcinoma by using invitro 
and invivo. 
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CHAPTER IV 
4. PLAN OF WORK 
 Collection and authentication of plant Nigella sativa. 
 Drying of plant stem 
 Ethanolic extraction of dried stem by cold maceration. 
 Preliminary phytochemical study of preapared Nigella staiva stem ex-
tract 
 Acute toxicity study of Nigella Sativa stem extract 
 Evaluation of Invitro cytotoxic activity 
 MTT Assay 
  Study of Invivo cytotoxic activity. 
 Evaluation in Dimethyl Hydrazine (DMH) induced colorectal 
carcinoma in male wistar rats 
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CHAPTER V 
5. PLANT PROFILE 
Fig.No 5:  Nigella sativa 
 
 
5.1. Taxonomical classification [64] 
Kingdom           :  Plantae 
Sub kingdom    :  Trachebionta 
Superdivision   :  Spermatophyta 
Division             :  Magnoliophyta 
Class                 :  Magnoliopsida 
Subclass           :  Magnoliidae 
Order                 :  Ranunculaceae 
Genus                :  Nigella.L 
Species              : Nigella sativa.L 
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5.2. Description: 
Annual herb,30-50 cm high, pubescent or glandular-hirsute. Leaves 
much divided, finely pinnate, leaf- segments linear to linear-lanceolate . Flow-
ers solitary at end of branches, blue, star-shaped, sepals 5, petaloid, oval c.7-
14x 6-8mm, shortly clawed; petals smaller than the sepals, 5(-8), nectarifer-
ous, with a bent claw and two lobes, stamens numerous, carpels 2-10 fused 
with five free styles. Fruit several follicles, crowned by persistent styles, many-
seeded, brownish when ripe; seeds dark grey to black, trigonous, wrinkled , 
white and oleaginous inside, aromatic. 
5.3.Habitat & Distribution: 
The plant is found wild in southern Europe, northern Africa , Asia Minor 
and in the Mediterranean region, but has been cultivated into other parts of 
the world includingSaudi Arabia, Mediterranean countries, northern Africa and 
parts of Asia, in UAE rarely cultivated in private farms. 
  
5.4.Table 2 :Vernacular Names 
 
English Black-caraway, black-cumin, fen-
nel-flower, nigella, nutmeg-flower 
Hindi Kalonji 
Bengali Mogrel 
Malayalam Karum Jiragam 
Marathi Kale Til 
Tamil Karum jeera 
 
5.5.Nigella Sativa seed Benefits[65] 
It is reported to have the following medicinal benefits already 
 Pain killing  
 Antibacterial 
 Anti inflammatory and Pro aptosis[66] 
 Anti ulcer  
 Anti cholinergic 
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 Anti Fungal 
 Anti hypertensive 
 Antispasmodic 
 Anti viral  
 Bronchodilator 
 Anti Diabetic 
 Liver protecting 
 Hypotensive 
 Insulin sensitizing 
 Leukotriene antagonist 
 Tumour necrosis factor 
 Alpha inhibitor 
 Anti oxidant 
Nigella sativa seeds were used against Cough, Amenorrhoea, Thermogenic, 
Carminative, Diuretic, Emmenegogue, Anodye, Antibacterial, Antiinflammato-
ry already.   
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CHAPTER VI  
6. MATERIALS AND METHODS 
6.1.Collection And Authentification Of Plant 
The stem of Nigella Sativa was procured from the Botany Central 
council for Research in Ayurvedia and Siddha Govt of India and authenticated 
by Chelladurai.V research officer Botany Central council for Research in 
Ayurved and Siddha Govt of India. CERTIFICATE NO:UWAN/109/16 
 
6.2.Extraction of Nigella Sativa Stem 
Stem material was shade dried in room temperature for 3 days and then 
coarsely powdered.  
Powdered plant material (500g) was defatted using hexane and defatted ma-
terial was extracted with (2000 ml ×3) of methanol which was kept overnight 
(cold maceration) and filtered, filtrate was  completely evaporated under re-
duced pressure using Rotavapor (MeBG) yield 13.6%w/w.  
The spent material after ethanol extraction was extracted with distilled water 
(2000 ml×3) filtered and filtrate was completely dried under reduced pressure 
using Rotavapor (WtBG) yield 25.2% w/w.  
The preliminary phytochemical study of defatted methanol extract indicated 
the presence of Anthraquinone glycosides, flavanoids, phenols, carbohy-
drates. 
6.3.Phytochemical Screening[67] 
6.3.1.Test for carbohydrates 
Molisch’s test: Dissolve small quantity of 300mg alcoholic and dried leaf ex-
tract of Nigella Sativa separately in 4ml distilled water and filter. The filtrate 
have to be subjected to Molisch’s test.  
Fehling’s test: Dissolve a small portion of NS stem extract in water and treat 
with Fehling’s solution. 
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6.3.2.Test for phenols  
Spot NS stem extract on a filter paper. Add a drop of phosphomolybdic acid 
reagent  to the spot and expose to ammonia vapours.. 
6.3.3.Test for flavanoids  
Shinoda test: To 2 to 3ml of NS extract, a piece of magnesium ribbon and 1ml 
of concentrated HCl has to be added .  
Lead acetate test: To 5ml of NS stem extract add 1ml of lead acetate solu-
tion.. 
6.3.4Test for tannins 
Braemer’s test: To a 2 to 3ml of NS stem extract,add 10% alcoholic ferric 
chloride solution.. 
6.3.5Test for steroid/terpenoid 
Liebermann-Burchardt test: To 1ml of Nigella Sativa stem extract, add 1ml of 
chloroform, 2 to3ml of acetic anhydride and 1 to 2 drops of concentrated Sul-
phuric acid. If Dark green coloration of the solution takes place it indicates the 
presence of steroids and dark pink or red coloration of the solution indicates 
the presence of terpenoids. 
6.3.5. Test for alkaloids 
Draggendorf’s test: A drop Nigella Sativa stem extract was spotted on a small 
piece of precoated TLC plate and the plate was sprayed with modified 
Draggendorf’s reagent.  
Hager’s test: Treat the Nigella Sativa stem extract  with few ml of Hager’s re-
agent. 
Wagner’s test: Add few ml of Wagner’s reagent to Nigella Sativa stem ex-
tract.. 
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6.3.6.Tests for Glycosides  
Legal’s test: Dissolved the Nigella Sativa stem extract [0.1g] in pyridine [2ml], 
add sodium nitroprusside solution [2ml] and made alkaline with Sodium hy-
droxide solution.  
6.3.7.Test for Saponins 
Foam test: 1ml of Nigella Sativa stem extract was dilute with 20ml of distilled 
water and shaken with a graduated cylinder for 15 minutes 
6.3.8.Test for Anthraquinones 
Borntrager’s test: Add about 50 mg of powdered Nigella Sativa stem extract 
withd with 10% ferric chloride solution and 1ml of concentrated HCl. The ex-
tract has to be cooled, filtered and shake the filtrate with diethyl ether. The 
ether extract  further extraction with strong ammonia . 
6.3.9.Test for Amino acids 
Ninhydrin test: Dissolve a small quantity of the Nigella Sativa stem extract in 
few ml of water and adde 1ml of ninhydrin reagent. 
6.3.10.Test for fixed oils and fats 
Press small quantity of the Nigella Sativa stem extract between two filter pa-
per.  
6.4. invitro Anticancer activity 
6.4.1.MTT assay[68] 
Reagents 
PBS 
MTT (5 mg/ml in PBS) – filter and keep dark, prepare freshly 
Acidic isopropanol (0.1N HCl in absolute isopropanol) 
96-well plate (flat bottom) 
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Protocol 
 
MTT Assay   
 
1. For adherent cells, remove the medium and replace it with 100 µL of 
fresh culture medium. For non-adherent cells, centrifuge the micro-
plate, pellet the cells, carefully remove as much medium as possible 
and replace it with 100 µL of fresh medium. 
2. Add 10 µL of the 12 mM MTT stock solution (prepared in step 1.1) to 
each well. Include a negative control of 10 µL of the MTT stock solution 
added to 100 µL of medium alone.  
3. Incubate at 37°C for 4 hours. At high cell densities (>100,000 cells per 
well) the incubation time can be shortened to 2 hours. 
4. Add 100 µL of the SDS-HCl solution (prepared in step 1.2) to each well 
and mix thoroughly using the pipette. 
5. Incubate the microplate at 37°C for 4– hours in a humidified chamber. 
Longer incubations will decrease the sensitivity of the assay. 
6. Mix each sample again using a pipette and read absorbance at 570 
nm. 
Percentage inhibition of the extract against all cell line was calculated 
using the following 
formula. 
 
% of cell survival =  ሺ𝐀𝐭 − 𝐀܊ሻ ÷ ሺ𝐀܋ − 𝐀܊ሻ 
At = Absorbance of Test, 
Ab= Absorbance of Blank (Media), 
Ac= Absorbance of control (cells) 
% cell inhibition = 100 - % cell survival 
The effects of extracts were expressed by IC50 values calculated from 
dose response curves. 
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6.5. Acute toxicity study 
The acute oral toxicity study was to be conducted in compliance with 
OECD guideline 423, Animals were fasted overnight (~12 h) and weighed. 
Test doses of Nigella Sativa stem ethanolic extract were calculated in relation 
to the body weight of every fasted animal, and administered via oral gavage at 
2000 mg/kg. The animals were regularly and individually observed for behav-
ioral changes and general toxicity signs after dosing for the first 24 h, with 
special attention being given during the first 4 h. Thereafter, observation was 
continued daily for a total of 14 days.Mortality was Nil. But observed some 
behavioural changes and writhing response and loose stools  at the dose of 
2000mg/kg. Hence 1/5th and 1/10th dose of 2000mg/kg i.e.; 200mg/kg and 
400mg/kg have been used 
Table .No:3. 
6.6.Evaluation of invivo anti colon cancer activity  
6.6.1.Test animal 
 Male wistar rats of 6-8weeks old 
6.6.2.Housing 
The experimental animal room temperature maintained at 22°C±3°C 
OECD guideline-425, 2001. These ranges are designed to allow homeo-
therms to maintain metabolic rate or to be within their thermo neutral zones. 
Because, temperature below the recommended range leads to increased food 
Group Dose(mg/kg) 
Group I 5 
Group II 50 
Group III 500 
Group IV 2000 
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intake, increased energy expenditure but decrease in efficiency. In contrast, 
temperature above the recommended range leads to decreased food.  
6.6.3.Humidity 
The relative humidity maintained at 40%-60% preferably not exceeds 
70% (OECD-425, 2001).The relative humidity below the recommended range 
can develop lesions such as ring tail and food consumption may be increased 
take. 
6.6.4.Light  
12-12 hours, Light/dark cycle. Appropriate lighting and light cycle play a 
key role in maintaining the physiology and the behavior rat. Light provided for 
adequate vision and for neuroendocrine regulation of diurnal and circadian 
cycles (CPCSEA guidelines for laboratory animal facility 2003). 
6.6.5.Caging  
Polypropylene cages with solid bottom and walls. Lids made up of 
stainless steel grill capable of holding of both feed and water. 4 to 5 is put per 
cage.  
 
6.6.6.Feeding condition  
 Sterile laboratory feed (ad libitum) and RO water bottles daily.  
Feed – Brown colored chow diet. 
6.6.7.Drug administration 
Animals wre normally provided with food ad libitum. And weighed prior 
to study. In these theree groups Group 1 served as normal control which re-
ceived vehicle(gum acasia suspension),Group 2 prepared as disease control 
were given intra peritoneal injection of DMH twice a week for two consecutive 
weeks at a dose of 30 mg/kg body weight. And the group 3 where the same 
aforementioned method used to induce colorectal cancer treated with Nigella 
Sativa stem extract at a dose of 200mg/kg body weight daily for total 30 days 
of study period by oral route. 
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6.6.8.Clinical observations 
All rats were monitored continuously for 4 hour after dosing for signs of 
toxicity. For the remainder of the 14 days study period, animals were moni-
tored and any additional behavioral or clinical signs of toxicity. Animal’s body 
weight was measured prior to dosing and on days 7 and 14.On all animals 
were killed and at the end of the study LD50 value was established. Clinical 
observations and gross pathological examination was carried out. 
6.6.9.DMH induced colon cancer 
6.6.9.1. Animals  
Healthy adult male wistar rats 18 numberes are procured and assigned 
to three groups. In these theree groups Group 1 served as normal control 
which received vehicle(gum acasia suspension),Group 2 prepared as disease 
control were given intra peritoneal injection of DMH twice a week for two con-
secutive weeks at a dose of 30 mg/kg body weight. And the group 3 and 4 
where the same aforementioned method used to induce colorectal cancer 
treated with Nigella Sativa Stem extract at a dose of 200mg/kg  and 400 
mg/kg body weight daily for total 30 days of study period by oral route.   The 
animals were kept in polypropylene cages (4 per cage) and fed standard pel-
let diet for 1 week. Thereafter, the animals were randomly divided into three 
groups each containing 6 rats and maintained under controlled conditions of 
temperature (24 ± 2 °C), humidity (50 ± 10%), and 12-h light/dark cycle and 
tap water was provided ad libitum. 
DMH had to be dissolved in 1mM EDTA just before use and pH was adjusted 
with NaOH to confirm the stability of carcinogen [69]. Rats of Group 2 & 3 are 
given with intra peritoneal injections of DMH twice a week for 2 weeks at a 
dose of 20 mg/kg of body weight. 
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6.6.9.2. Table No 4 : Invivo anti-cancer study – Animal grouping 
Group Treatment 
1 Normal control which receive vehicle 
2 Disease control where 30 m/kg of i.p injection of DMH given 
twice for 2 consecutive weeks. 
3 Treated group where DMH induced colon cancer symptoms were 
treated with prepared extract at a dose of 200 mg/kg body weight 
for 30 days 
4 Treated group Where DMH induced induced colon cancer symp-
toms were treated with prepared extract at a dose of 400 mg/kg 
body weight. 
 
 
6.6.9.3.Body weight changes 
  
The body weight changes of the control, DMH and nigella sativa stem 
extract treated rats were measured throughout the study. The rats were 
weighed at the beginning of the experiment and then subsequently once a 
week and finally before sacrifice. 
6.6.9.4.Determination of aberrant cryptic foci 
At the end of the study, rat colons were removed and flushed with po-
tassium phosphate buffered saline (0.1 M, pH 7.2). Colons were split open 
longitudinally and placed on strips of filter paper with their luminal surfaces 
open and exposed. Another strip of filter paper was placed on top of the lu-
minal surface. The colons were then secured and fixed in a tray containing 
10% buffered formalin overnight. Each of the fixed colons was cut into proxi-
mal and distal portions of equal lengths and each portion was further cut into 
2 cm long segments. Each segment was placed in a petridish and stained 
with 0.2% methylene blue solution for 2 min. The segments were examined 
using a light microscope at low magnification to score the total number of ACF 
as well as the number of crypts per focus. ACF were distinguished from nor-
mal crypts by their thicker, darker-stained, raised walls with elongated slit-like 
lumens and significantly increased distance from the lamina to basal surface 
of cells.[69] 
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6.6.9.5. Apoptosis measurement in colonic mucosa 
Apoptosis evaluation was carried out in paraffin-embedded sections of 
normal colonic mucosa and tumours stained with haematoxylin–eosin.[70] At 
least 20 full longitudinal crypt sections of normal mucosa/rat were scored at 
the microscope, determining the presence of cells in each crypt with the fol-
lowing characteristics of apoptosis: cell shrinkage, loss of normal contact with 
the adjacent cells of the crypt, chromatin condensation or formation of round 
or oval nuclear fragments (“apoptotic bodies”). When clusters of more than 
one apoptotic body were seen within the diameter of one cell, these bodies 
were considered as fragments of one apoptotic cell. Tumour apoptosis was 
determined by scoring at least 1000 cells/rat for the presence of apoptotic 
cells that were coded as described above.  
apoptotic index (AI) = Number of apoptotic cells/cells scored × 100). 
6.6.9.6. Colon crypt Histopathology 
Necropsy was performed for all rats sacrificed. 
Entire intestine was removed and large intestine portion is removed. 
Which were cut opened longitudinally. 
Then it is taken for wash with PBS. 
Mucosal surface lesions are noted and that portions are taken. 
Fixation performed by 4%V/V formalin in PBS overnight. 
Each segment was placed in a petridish and stained with 0.2% methylene 
blue solution for 2 min. The segments were examined using a light micro-
scope at low magnification to score the total number of ACF as well as the 
number of crypts per focus. 
 ACF were distinguished from normal crypts by their thicker, darker-stained, 
raised walls with elongated slit-like lumens and significantly increased dis-
tance from the lamina to basal surface of cells. ACFs in the colon were count-
ed as described by Bird 
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6.6.9.7. Haematological parametres 
Blood samples were collected for haematological analysis in Vacutain-
er tubes with 1.5% EDTA and differentially quantified through a Coulter T890 
for the following: WBC, RBC and platelet counts and hemoglobin determina-
tion. During the course of the study, the haematological parameters of the 
animals were tracked on every 5th day. For this, blood was collected from the 
caudal vein into heparinised tubes and total WBC count and haemoglobin 
level were checked. 
6.6.9.7.1. WBC Count 
The whole blood was diluted using a diluent which haemolyses red 
cells, leaving all the nucleated cells intact. The number of white cells in a 
known volume and known dilution were counted using a counting chamber.  
0.02 ml of blood was added to 0.38 ml of diluting fluid and mixed well. 
The diluted blood was charged into a Neubauer counting chamber. After 3-4 
min, the total number of white blood cells in the four large corner square 
chambers was counted.  
 Total WBC = (Number of cells counted x 50) / mm3    
 
6.6.9.7.2.Determination of haemoglobin (Hb) content: 
 Cyanmethaemoglobin method  
Haemoglobin was treated with a reagent containing potassium ferricyanide, 
potassium cyanide and potassium dihydrogen phosphate. The ferricyanide 
forms methaemoglobin, which is converted to cyanmethaemoglobin by cya-
nide. The intensity of colour formed is measured at 546 nm against blank. The 
optical density is directly proportional amount of hemoglobin. 
 
Procedure: 
0.02 ml of fresh whole blood was mixed with 5 ml of the cyanmeth rea-
gent. The optical density was measured at 546 nm against blank after 5 min 
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incubation at room temperature. The OD of standard solution corresponding 
to 60 mg/dl haemoglobin at 546 nm was also read against reagent blank. 
Haemoglobin (g/dL) = (OD of treated x 60 x 0.251) / OD of   standard 
During  necropsy, the liver, kidneys, colon, spleen, heart, pancreas, stomach, 
lungs were removed, and weighed[71] 
Statistical analysis  
Values are given as means ± SD of each group. Data were analyzed by one-
way  ANOVA. The results are considered statistically significant at P < 0.05. 
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CHAPTER VII 
7. RESULTS AND DISCUSSION 
7.1. Extraction of Nigella sativa stem  
Percentage yield of Nigella Sativa stem extract by cold maceration was found 
to be 10.2% w/w.  
Table.No: 5 Extraction of Nigella Sativa stem extract 
Plant name Part using Method of 
extraction 
Solvents Yield in per-
centage 
Nigella sati-
va 
Stem maceration ethanol 20.3 
 
7.2.Preliminary phyto chemical screening 
Niglla sativa stem extract were subjected to various chemical tests for identifi-
cation and reported. 
Molisch’s test- indicated Formation of reddish brown ring indicatng the pres-
ence of carbohydrates. 
Fehling’s test- brown color indicating the presence of carbohydrate. 
Test for Phenols- Blue coloration of the spot indicates the presence of phe-
nols A pink or red coloration of the solution indicates the presence of flavo-
noids in the drug.  
Shinoda test- Flocculent white precipitate indicated the presence of flavo-
noids. 
Braemer’s test- Dark blue or greenish grey coloration  present indicates the 
presence of tannins in the drug.  
Libermann Buchard test - Dark green coloration of the solution takes place it 
indicates the presence of steroids and dark pink or red coloration of the solu-
tion indicatesd the presence of terpenoids. 
Dragendroff’s test - Orange coloration of the spot indicated the presence of 
alkaloids.  
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Hager,s Test- Yellow precipitation indicated the presence of alkaloids 
Wagner’s test- The reddish brown precipitation indicated the presence of 
alkaloids 
Legal’s Test - Pink to red color solution indicated the presence of glycosides. 
Foam test - A 1cm layer of foam formation indicated the presence of Sapo-
nins 
Borntrager’s Test-  Pink or red coloration of aqueous layer indicated the 
presence of Anthraquinones 
Ninhydrin Test- Blue color  indicated the presence of amino acids. 
Test for fixed oils- Oil stains on the paper indicated the presence of fixed 
oils. 
Table No 6 : Preliminary phytochemical screening  of Nigella Sativa 
Stem extract 
Class of 
Compounds 
Tests performed Results 
Carbohydrate Molisch’s Test 
Fehling’s test 
- 
Phenols Phosphomolybidic test + 
Flavanoids Shinoda test 
Lead acetate test 
+ 
Tannins Braemer’s test - 
Alkaloids Wagner’s 
Mayer’s 
Draggendrof’s test 
- 
Glycosides Legal’s test 
Brontranger’s test 
+ 
Saponins Foam test + 
Sterols Salkowski’s test - 
Amino Acids Ninhydrin test - 
Terpenoids Libermann Burchardt test - 
 
NB: 
-indicate not present 
+  indicate presence 
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7.3 Acute toxicty study 
The animals were regularly and individually observed for behavioral 
changes and general toxicity signs after dosing for the first 24 h, with special 
attention being given during the first 4 h. Thereafter, observation was contin-
ued daily for a total of 14 days.Mortality was Nil. But observed some behav-
ioural changes and writhing response and loose stools  at the dose of 
2000mg/kg. Hence 1/5th and 1/10th dose of 2000mg/kg 
i.e.; 200mg/kg and 400mg/kg have been used. 
 
Table.No.7:Changes in wellness parameters during acute toxicity study  
 Group 1 
(5mg/kg) 
Group 
2(50 
mg/kg) 
Group 
4(500 
mg/kg) 
Group 5 
(2000mg/kg) 
Alertness Normal Normal Normal Absent 
Anxiety Normal Normal Normal Normal 
Roaming Normal Normal Normal Normal 
Depression Normal Normal Normal Normal 
Writhing Absent Absent Absent Present 
Defaecation Normal Normal Normal Normal 
Urination Normal Normal Normal Normal 
Diarrhoea Absent Absent Absent Present 
Sleep Normal Normal Normal Abnormal 
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7.4.Invitro Anticancer Activity 
7.4.1. MTT assay 
This is a colorimetric assay where we measure the reduction of yel-
low3-(4,5 dimethyl thiazole-2-yl-)2-5-diphenyl tetrazolium bromide (MTT) by 
mitochondrial succinate dehydrogenase. When MTT get inside the cells and 
passes to mitochondria ,where it is reduced to an insoluble coloured Forma-
zan product. Reduction of MTT only occurs when cells are metabolically ac-
tive an the level of activity is measured by presence of formazan spectropho-
tometrically. 
Table No 8 : Invitro cytotoxic activity (MTT ASSAY) 
 
NS stem extract 
Sample Concentra-
tion (µg/ml) 
MTT assay  
% viability 
Control 98.50±0.35 
50 84.30±0.21 
100 75.45±0.26 
150 69.98±0.24 
200 58.80±0.29 
250 50.20±0.30 
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Graph 
MTT assay 
 
 
 
7.5.Body weight changes 
During the experimental period 30 days, the carcinogen-exposed rats 
(Group 2) exhibited a significantly (p< 0.05) low gain in body weight  and a low 
growth rate throughout the experimental period as compared to Groups 1 and 
3Oral administration of nigella sativa stem extract at a dose of 200 mg/kg b.w 
resulted in a significant improvement in weight gain relative to treatment with 
DMH alone. Values are mean ± SD, n=6 in each group, statistically significant 
**p<0.01,*p<0.05 when compared with disease control (DMH treated) group. 
Values are mean ± SD, n=6 in each group, statistically significant a**p<0.01, 
b*p<0.05 when compared with disease control (DMH treated) group. 
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Table No 9 : Body weight changes on treatment with ethanolic extract of 
Nigella sativa stem 
Group 
 
 
Initial 
weight(average) in 
grams 
Final weight(average
gms 
Weight gain 
Control 137.83 ± 15.68 158.33±9.66 
 
20.5±10.634** 
DMH treated 166.16±18.17 175.33±21.64 9.66±4.082 
DMH+NS stem 
extract treat-
ed(200 mg/kg) 
169.16±26.91 186.3±27.688 17.16±7.08* 
DMH+NS stem 
extract treat-
ed(400mg/kg) 
149±25.16 167±14.56 18.5±5.08* 
 
Graph 
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7.6. Aberrant crypt foci scoring 
ACF formation was observed in all DMH induced groups. The majority of ACF 
appeared in the distal colon of the rats injected with DMH. Oral administration 
of Nigella sativa stem extract at 200 mg/kg b.w.  could slightly inhibit the for-
mation as well as the total number of ACF , as compared to rats injected with 
DMH alone , but there was no reduction in number of aberrant crypt. Values 
are mean ±SD, n=6 in each group, statistically significant **p<0.01,*p<0.05 
when compared with disease control (DMH treated) group. Values are mean 
±SD, n=6 in each group, statistically significant a**p<0.01 when compared 
with disease control (DMH treated) group. 
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Table .No: 10 : Distribution of altered aberrant crypt foci (ACF) category 
in proximal, distal and total colon of rats exposed to DMH and Nigella 
sativa stem extract. 
 
Group Animal 
Nos 
Drug   Dose (Mg/kg) 
& routemof 
adminstration 
Total num-
ber of ACF 
Proximal colon 
Control 6 vehicle Oral 0 
DMH 6 DMH  30mg/kg i.p 14.66±2.33 
DMH&NSSE(200 
mg/kg) 
6 DMH+NSSE 30mg/kg i.p + 
200 mg/kg 
oral 
9± 3.1** 
DMH&NSSE(400mg/kg) 6 DMH+NSSE 30mg/kg i.p + 
400 mg/kg 
oral 
6±1.53** 
Distal colon 
Control 6 Vehicle Oral 0 
DMH 6 DMH 30mg/kg i.p 25.83±4.3 
DMH&NSSE(200mg/kg) 
(400mg/kg) 
6 DMH+NSSE 30mg/kg i.p + 
200 mg/kg 
oral 
18.5±3.08** 
DMH&NSSE(400mg/kg) 
(400mg/kg) 
6 DMH+NSSE 30mg/kg i.p + 
400 mg/kg 
oral 
15±2.33** 
Total colon 
Control 6 VEHICLE Oral 0 
DMH 6 DMH 30mg/kg i.p 40.49±6.3 
DMH&NS treat-
ed(200mg/kg) 
6 DMH+NSSE 30mg/kg i.p + 
200 mg/kg 
oral 
27.5±6.18** 
DMH&NSSE(400mg/kg) 6 DMH+NSSE 30mg/kg i.p + 
400 mg/kg 
20±5.13** 
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Graph 
ACF Scoring 
 
7.7.Apoptosis Scoring 
The apoptosis index (AI %) was estimated as the percentage of apoptotic 
cells among the total number of counted cells in a whole colonic crypt. The 
apoptotic index was increased in groups treated with DMH+NS extract com-
pared to only DMH treated group. Values are mean ±SD, n=6 in each group, 
statistically significant **p<0.01when compared with disease control (DMH 
treated) group  
 
Table.No:11 : Apoptosis Scoring 
Effect of Nigella Sativa and DMH on apoptotic indexes. 
 
Group Apoptosis index 
Control 3.53±0.46*** 
DMH 0.9±0.37 
 
DMH+nigella sativa stem ex-
tract(200mg/kg) 
2±0.63** 
DMH+NSSE(400mg/kg) 2.41±0.52** 
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Graph 
 
 
7.8.Histopathology of Colon crypt 
In control group of animals normal crypt can be viewed . But in DMH 
treated animals it shows thickened mucosa with densely packed inflammatory 
cell infiltration and hyperplasia. In third group where DMH induced cryptic foci 
were treated with 200mg/kg b.w Nigella sativa stem extract showed thickened 
mucosa in some got scattered. 
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Histopathology of colon crypt 
Fig. No: 9 
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7.9. Haematological parameters  
 
Values are mean±SD, n=6 in each group, statistically not significant p>0.05, 
when compared with disease control (DMH treated) group. There couldn’t find 
any significant changes in haemetological parametres before and after treat-
ment. 
 
 
 
 
Table No 12 : Effect of Nigella Sativa stem extract and DMH on various 
haematological parameters. 
 
Haemoto-
logical 
parame-
ters  
 
 
Change in haemotological parameters after induction 
 
Control 
 
DMH DMH+NS Ex-
tract 
DMH+NS Ex-
tract 
Be-
fore  
after Be-
fore 
After Before After Be-
fore 
After 
WBC  
(cells/μL×1
03  
9.1±1
.7 
 
9.97±
2.4 
6.06±
1.89 
 
8.53±
2.42 
 
10.2±3
.41 
 
10.56±
4.27 
 
9.23±
2.42 
90.12
±2.2 
RBC  
(cells/μL×1
06  
6.5±0
.05 
 
7.10±
0.26 
 
4.24±
1 
 
5.09±
1 
 
5.12±1
.04 
 
6.5±0.
69 
 
6.23±
2.1 
4.5±2.
41 
HGB(g/dL)  
 
11.3±
1.8 
 
11.9±
1.04 
 
11.1±
2.32 
 
11.9±
2.04 
 
9.4±2.
51 
 
12.6±1
.41 
 
9.5±5.
1 
9.3±2.
1 
PLT  
(cells/μL×1
03)  
256±
57 
 
291±5
10 
 
195±9
7 
 
222±8
1.3 
 
243.3±
87.7 
 
272±3
6 
 
256±5
0 
280±3
0 
 
 
7.10.Relative weight of organs 
Values are mean±SD, n=6 in each group, statistically not significant 
p>0.05, when compared with disease control (DMH treated)group. Relative 
weight of various organs when noted couldn’t find any variations before and 
after treatment. 
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Table No 13: Effect of Nigella Sativa stem extract and DMH on relative 
weight of organs 
Relative 
weight of or-
gans(weight 
of organ/100) 
Group 
Control DMH DMH+NS 
stem ex-
tract 
DMH+NS stem 
ex-
tract(400mg/kg) 
Liver 3.369±0.3
3 
3.69±0.22 3.11±2.56 3.4±2.56 
Kidney 0.826±0.0
7 
0.83±0.19 0.79±0.07 0.81±0.07 
Heart 0.413±0.0
4 
0.382±0.09 0.24±0.06
5 
0.45±0.084 
Lungs 0.859±0.1 0.748±0.029
9 
0.5±0.084 0.62±0.04 
Pancreas 0.04±0.06 0.391±0.165 0.47±0.09 0.49±0.08 
 
The increasing rate of colorectal cancer has brought an conclusion 
about the role of change in food habitats and adoption of western life style in 
neoplasm [72] . Death due to colorectal cancer have reported due to late diag-
nosis and treatment. 
 As we discussed earlier since “prevention is better than cure”  I have 
focussed my work on chemoprevention which aim at reducing the intensity of 
incidence of cancer with herbal remedies. 
Hydrazine and its derivatives like DMH are such chemicals that are 
shown to be carcinogenic and mutagenic [73] DMH, an alkylating agent, when 
injected intraperitonially, is transported to the liver where it undergoes dehy-
drogenation and is converted to an active carbonium ion through several pro-
cesses, to be excreted in the bile, where it mediates its carcinogenic activities 
on the mucosa while passing through the digestive tract.[74]  
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Aberrant crypts at colon are the earliest identifiable indication for colon 
cancer. These crypts appear by an increased size thicker and deeply stained 
epithelial lining and increased pericryptal zones.[75] They are putative neo-
plastic lesions of the colon.Budding and branching process, of crypts with 
outward pushed cells are known as crypt fission, which forms larger sized foci 
over time[76]. They appear within two weeks after carcinogen injectionas single 
crypts that expand by crypt branching or multiplication. ACF containing four or 
more crypts is known to correspond to the promotion stage of colon carcino-
genesis 
This study performed the evaluation of anticancer effect of a  Nigella 
sativa  stem extract both invivo and invitro for colon cancer. 
Phytochemical screening of Nigella sativa stem extract shows the 
presence of phenols,saponins,and flavanoids. 
Invitro cytotoxic study of nigella sativa  stem extract performed by MTT 
assay. Which indicated a decrease in cell viability with increased dose of ex-
tract of Nigella Sativa stem. It is specific to colonic epithelium as a result of 
incomplete repair of DNA in the colon compared to other organ tissues. 
In invivo screening performed by DMH induced colorectal chang-
es.DMH is a colon carcinogen. 
Results of invivo pharmacological screening shows that oral admin-
istration of NS stem extract brought a reduction in ACF to a small extent in 
comparison with normal control and DMH only treated group.  
There were no significant changes in the relative weight of individual 
organs among the groups and also in haematological parameters. Histology 
of  The results of the present study demonstrated that administration of etha-
nolic extract of Nigella sativa stem at a dose of 200mg/kg body weight during 
either the initiation, post-initiation or entire period phase could bring slight in-
hibition DMH-induced colon carcinogenesis in rats. 
A common feature of GI tumours is weight loss which shows aggres-
siveness of the disease. Similiarly DMH treated groups shown reduction in 
57 
 
weight gain compared to normal control rats.In this study colon were exam-
ined for ACF 30days after the first injection of DMH i.p. Crypts were observed 
at proximal and distal colon. 
Herb based drug industry is growing day by day. The destruction of 
natural habitats over exploitation and unsustainable harvest has lead to a se-
vere scarcity of raw material. These problems have adversely affected the 
quantity of herbal drugs.  
In this study we used DMH as colon cancer inducer and ethanolic ex-
tract of stem of Nigella Sativa as the test drug. The purpose of this investiga-
tion, which is a part of a large-scale study to prove the inhibitory effect of Ni-
gella Sativa on colon cancer using established colon cancer model. 
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CHAPTER VIII 
8. SUMMARY AND CONCLUSION 
The current work revealed that the Nigella sativa stem shows anti-cancer 
activity  comapred to normal. High light of this study is extraction with methanol 
and it’s phytochemical screening. Phytochemical study shows the presence of 
phenols, flavanoids, saponins ,and glycosides. Invivo study of Nigella Sativa 
stem extract was performed in DMH induced colon carcinogenesis. The results of 
present study showed that the supplementation of Nigella sativa to the diets of 
rats for 28 days did not change the haemetological parameters as well as histo-
pathological examinations which illustrated normal architecture of liver and heart 
after treatment. It’s proved by no significant changes of serum ALT and AST level 
in treatment group compare to the control group. Absence of pathological condi-
tion of liver tissue in histological evaluation confirmed the result. This study also 
found that body weights of the rats in all groups are maintained during the exper-
iment which indicating healthy status of animals. Invitro evaluation performed by 
MTT assay shows decreased cell viability with increasing concentrations of ex-
tract being cytotoxic. The identification of chemical compounds present in the 
stem of Nigella sativa stem which are responsible for the specific activity is re-
maining.  
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